BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 32272850)

  • 1. A comparative pulmonary pharmacokinetic study of budesonide using polymeric nanoparticles targeted to the lungs in treatment of asthma.
    Ahmad N; Ahmad R; Almakhamel MZ; Ansari K; Amir M; Ahmad W; Ali A; Ahmad FJ
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):749-762. PubMed ID: 32272850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Chitosan-PLGA based catechin hydrate nanoparticles used in targeting of lungs and cancer treatment.
    Ahmad N; Ahmad R; Alrasheed RA; Almatar HMA; Al-Ramadan AS; Buheazah TM; AlHomoud HS; Al-Nasif HA; Alam MA
    Saudi J Biol Sci; 2020 Sep; 27(9):2344-2357. PubMed ID: 32884416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daunorubicin oral bioavailability enhancement by surface coated natural biodegradable macromolecule chitosan based polymeric nanoparticles.
    Ahmad N; Ahmad R; Alam MA; Ahmad FJ; Amir M; Pottoo FH; Sarafroz M; Jafar M; Umar K
    Int J Biol Macromol; 2019 May; 128():825-838. PubMed ID: 30690115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain-targeted glycyrrhizic-acid-loaded surface decorated nanoparticles for treatment of cerebral ischaemia and its toxicity assessment.
    Ahmad N; Al-Subaiec AM; Ahmad R; Sharma S; Alam MA; Ashafaq M; Abdur Rub R; Ahmad FJ
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):475-490. PubMed ID: 30739499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification and Evaluations of Catechin Hydrate Polymeric Nanoparticles Used in Brain Targeting for the Treatment of Epilepsy.
    Ahmad N; Ahmad R; Alrasheed RA; Almatar HMA; Al-Ramadan AS; Amir M; Sarafroz M
    Pharmaceutics; 2020 Feb; 12(3):. PubMed ID: 32120778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of oral efficacy of Irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations.
    Ahmad N; Alam MA; Ahmad R; Umar S; Jalees Ahmad F
    J Microencapsul; 2018 Jun; 35(4):327-343. PubMed ID: 29873288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification and Brain Targeting of Eugenol-Loaded Surface Modified Nanoparticles Through Intranasal Route in the Treatment of Cerebral Ischemia.
    Ahmad N; Ahmad R; Alam MA; Ahmad FJ
    Drug Res (Stuttg); 2018 Oct; 68(10):584-595. PubMed ID: 29669380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
    Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
    Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of oral bioavailability of doxorubicin through surface modified biodegradable polymeric nanoparticles.
    Ahmad N; Ahmad R; Alam MA; Ahmad FJ
    Chem Cent J; 2018 May; 12(1):65. PubMed ID: 29796830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of Budesonide-Loaded Liposomal Nanoparticles for Pulmonary Delivery and Their Therapeutic Effect in OVA-Induced Asthma in Mice.
    Zuo X; Gu Y; Guo X; Zheng W; Zheng H; An Y; Xu C; Wang F
    Int J Nanomedicine; 2024; 19():673-688. PubMed ID: 38283200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Poly(vinyl alcohol) on Nanoencapsulation of Budesonide in Chitosan Nanoparticles via Ionic Gelation and Its Improved Bioavailability.
    Michailidou G; Ainali NM; Xanthopoulou E; Nanaki S; Kostoglou M; Koukaras EN; Bikiaris DN
    Polymers (Basel); 2020 May; 12(5):. PubMed ID: 32408557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted delivery of budesonide in acetic acid induced colitis: impact on miR-21 and E-cadherin expression.
    Seoudi SS; Allam EA; El-Kamel AH; Elkafrawy H; El-Moslemany RM
    Drug Deliv Transl Res; 2023 Nov; 13(11):2930-2947. PubMed ID: 37184747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-assembled nanoparticles based on amphiphilic chitosan derivative and arginine for oral curcumin delivery.
    Raja MA; Zeenat S; Arif M; Liu C
    Int J Nanomedicine; 2016; 11():4397-4412. PubMed ID: 27660435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bioanalytical UHPLC based method used for the quantification of Thymoquinone-loaded-PLGA-nanoparticles in the treatment of epilepsy.
    Ahmad N; Ahmad R; Al Qatifi S; Alessa M; Al Hajji H; Sarafroz M
    BMC Chem; 2020 Dec; 14(1):10. PubMed ID: 32083254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lentinan-Based Oral Nanoparticle Loaded Budesonide With Macrophage-Targeting Ability for Treatment of Ulcerative Colitis.
    Lin M; Dong L; Chen Q; Xu H; Han X; Luo R; Pu X; Qi S; Nie W; Ma M; Wang Y; Gao F; Zhang J
    Front Bioeng Biotechnol; 2021; 9():702173. PubMed ID: 34513811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of budesonide nanosuspensions for pulmonary delivery: Characterization, in vitro release and in vivo lung distribution studies.
    Zhang Y; Zhang J
    Artif Cells Nanomed Biotechnol; 2016; 44(1):285-9. PubMed ID: 25100657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucopenetrating nanoparticles for enhancement of oral bioavailability of furosemide: In vitro and in vivo evaluation/sub-acute toxicity study.
    Radwan SE; Sokar MS; Abdelmonsif DA; El-Kamel AH
    Int J Pharm; 2017 Jun; 526(1-2):366-379. PubMed ID: 28487189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of rutin in rat's brain by UHPLC/ESI-Q-TOF-MS/MS after intranasal administration of rutin loaded chitosan nanoparticles.
    Ahmad N; Ahmad R; Naqvi AA; Alam MA; Samim M; Iqbal Z; Ahmad FJ
    EXCLI J; 2016; 15():518-531. PubMed ID: 28096783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose and steady-state pharmacokinetic and pharmacodynamic evaluation of therapeutically clinically equivalent doses of inhaled fluticasone propionate and budesonide, given as Diskus or Turbohaler dry-powder inhalers to healthy subjects.
    Möllmann H; Wagner M; Krishnaswami S; Dimova H; Tang Y; Falcoz C; Daley-Yates PT; Krieg M; Stöckmann R; Barth J; Lawlor C; Möllmann AC; Derendorf H; Hochhaus G
    J Clin Pharmacol; 2001 Dec; 41(12):1329-38. PubMed ID: 11762560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.